Iscalimab is a monoclonal antibody commercialized by Novartis, with a leading Phase II program in Lupus Nephritis.

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

And research published in August found that liraglutide, an anti-obesity medication, can help restore adaptive learning abilities in those with obesity. What researchers are finding is that brain ...

A study has identified the key role of lateral septum neurons in the effects of the anti-obesity drug liraglutide, offering ...

Sales approval for the company’s anti-obesity drug mazdutide may drag out beyond this year, potentially allowing rival ...

The success of weight-loss injections has prompted pharmaceutical companies to produce a next-generation anti-obesity pill ...

The growth of highly sought-after weight-loss drugs like Wegovy and Ozempic, otherwise known as GLP-1 medications, represents ...

A research group led by Prof. Zhu Yingjie from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of ...

The North Chicago drugmaker could have a new foe — or frenemy — in a fellow Big Pharma firm trying to find wider uses for its ...

A new study has settled a prolonged dispute within the medical community by showing that mutations associated with clonal ...